Related Experiment Videos
[Changes in thrombocyte aggregation in patients with type I diabetes]
P Tison1, V Mojto, B Gregorová
1III. interná klinika LFUK, Bratislave.
Bratislavske Lekarske Listy
|October 1, 1994
Summary
Platelet aggregation in type 1 diabetes shows sex-specific changes, with reduced sensitivity in males and females compared to controls. Clinically manifested diabetic nephropathy may influence these platelet alterations.
Area of Science:
- Endocrinology
- Hematology
- Nephrology
Context:
- Diabetes mellitus type 1 is a complex metabolic disorder.
- Platelet aggregation plays a role in cardiovascular health.
- Diabetic nephropathy is a common complication of diabetes.
Purpose:
- To evaluate platelet aggregation in patients with type 1 diabetes mellitus.
- To investigate the influence of diabetic nephropathy and sex on platelet aggregation.
Summary:
- Automated analysis of platelet aggregation in 80 type 1 diabetes patients revealed no significant global changes. However, the area under the aggregation curve was minimal in patients with clinically manifested diabetic nephropathy.
- Sex-specific analysis showed reduced platelet sensitivity to ADP in male diabetics versus controls. Female diabetics exhibited lower aggregation curve area and transmittance compared to female controls.
- These findings suggest platelet aggregatory polymorphism in diabetes, potentially influenced by nephropathy, and support the utility of antiplatelet therapy.
Impact:
- Highlights potential sex differences in platelet dysfunction in diabetes.
- Suggests diabetic nephropathy may modulate platelet aggregation.
- Provides evidence supporting the use of antiplatelet therapy in managing diabetes-related complications.